Clinical Trial Update: Effect of Food on Blood Levels of ASTX727 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the impact of food on plasma levels of ASTX727 (decitabine/cedazuridine) in patients with myelodysplastic syndromes, chronic myelomonoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• ASTX727 (cedazuridine/decitabine)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 1 | Status: COMPLETED